In addition, Zhou et al. reported that flumethasone, a glucocorticoid agonist, suppresses the expression of NRF2 in lung cancer cells and sensitizes them to cisplatin, doxorubicin, and 5-FU [14]. Here, NFE2L2 is linked to lung carcinoma.